With 12 years of experience in the healthcare sector, Dr. Duygu Ölmez, who has successfully fulfilled roles such as Medical Consultant, Senior Regulatory Affairs Manager, and Strategic Project Leader at Alexion Turkey, has been appointed as the Alexion Turkey Market Access Director.
With 17 years of career experience in sales and marketing management in the pharmaceutical sector, Belma Bozkurt, MBA, who has successfully executed numerous projects, brings extensive expertise and achievements in launch, licensee relations, original, generic molecules, and biotechnology. She has been appointed as the Alexion Turkey Hematology & Nephrology Franchise Lead.
Having undertaken significant responsibilities as a medical manager in local and international roles in the cardiovascular, metabolism, respiratory, and oncology therapeutic areas, Dr. Oguz Yilmazer has been appointed as the Alexion Turkey Senior Medical Director. In addition to his new role, Yilmazer is also an Alexion International Medical Leadership Team member.
Having successfully executed roles in Regional Sales Management, National Sales Management, and Sales Directorship positions at Alexion Turkey, and possessing extensive experience in various therapeutic areas, as well as in original and biotechnology products, Emre Aktolga has been appointed as the Alexion Turkey Neurology Franchise Lead.
Derya Erturun Köker, General Manager of Alexion Pharmaceuticals Turkey, commented on the new appointments: “In line with our ethical values, together with our qualified team, we offer innovative drugs, supportive technologies, and healthcare services that help transform the lives of people and families affected by rare diseases. In Turkey, we have a team of 53 talented and professional members. We are committed to promoting gender equality, diversity, and inclusivity. In 2023, we expanded our team by creating new employment opportunities, achieving a 40% increase. I wish success to my colleagues in their new roles.”
